Evidence map›Paper›PMID 35755142›Full record

ArticleVaccine: X2022

Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas.

Thomas G Boyce, Ben Christianson, Kayla E Hanson, Denise Dunn, Elizabeth Polter, Jeffrey J VanWormer, Charnetta L Williams, Edward A Belongia, Huong Q McLean

Abstract read
In one paragraph

Article in Vaccine: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Rural-urban disparities in human papillomavirus vaccination: Findings from a cross-sectional survey of 13 southern US states, December 2019-January 2020.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thomas G BoyceMarshfield Clinic Research Institute, Marshfield, WI, USA.
Ben ChristiansonMinnesota Department of Health, St. Paul, MN, USA.
Kayla E HansonMarshfield Clinic Research Institute, Marshfield, WI, USA.
Denise DunnMinnesota Department of Health, St. Paul, MN, USA.
Elizabeth PolterMinnesota Department of Health, St. Paul, MN, USA.
Jeffrey J VanWormerMarshfield Clinic Research Institute, Marshfield, WI, USA.
Charnetta L WilliamsImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Edward A BelongiaMarshfield Clinic Research Institute, Marshfield, WI, USA.
Huong Q McLeanMarshfield Clinic Research Institute, Marshfield, WI, USA.

Funding

Understanding and Addressing the Disparity in Vaccination Coverage Among U.S. Adolescents Living in Rural Versus Urban AreasU01IP001093 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI NGUYEN, HUONG Q · 2018 to 2020
$1.1M
NCIRD CDC HHS U01 IP001093
6 · The paper itself

Abstract

Background: Studies have shown that adolescent vaccination rates with human papillomavirus (HPV) and quadrivalent meningococcal conjugate (MenACWY) vaccines are lower in rural areas of the U.S. than in urban areas. We sought to determine factors associated with vaccine acceptance in these two settings. Methods: We conducted a cross-sectional survey of 536 parents or guardians of teens age 13 through 15 years in select rural and urban counties of Minnesota and Wisconsin. We collected information on demographic variables, receipt of adolescent vaccines, and attitudes toward HPV vaccine in particular. Multivariable logistic regression models were used to assess associations between covariates and outcomes of interest (HPV vaccine receipt and MenACWY receipt). Results: Of the 536 respondents, 267 (50%) resided in a rural county. Most respondents were female (78%) and non-Hispanic White (88%). About half (52%) of teens of the surveyed parents received the three vaccines recommended specifically for adolescents: 90% received tetanus-diphtheria-acellular pertussis (Tdap), 84% received MenACWY, and 60% received one or more doses of HPV vaccine. Rural and urban parents surveyed differed on several covariates relating to teen's health services, parent's demographics, and household characteristics. Parent's perception of the importance that their healthcare providers placed on vaccination with HPV and MenACWY were independently associated with receipt of each of those vaccines (odds ratio [OR] 6.37, 95% confidence interval [CI] 2.90-13.96 and OR 2.15, 95% CI 1.07-4.31, respectively). Parents of vaccinated teens were less likely to report concerns about potential harm from the HPV vaccine or having heard stories about health problems caused by the HPV vaccine. Conclusion: Teen receipt of HPV vaccine and MenACWY appears to be influenced by parents' perception of vaccine importance, provider recommendations, and concerns regarding potential harm from the HPV vaccine. Continued education of providers and parents of the importance of adolescent vaccinations is warranted.

Indexed as

AdolescentCDC, Centers for Disease Control and PreventionCHIAS, Carolina HPV Immunization Attitudes and Beliefs ScaleHPV, human papillomavirusHuman papillomavirusIIS, immunization information systemIRB, Institutional Review BoardMCRI, Marshfield Clinic Research InstituteMDH, Minnesota Department of HealthMenACWY, quadrivalent meningococcal conjugate vaccineMIIC, Minnesota Immunization Information ConnectionRural populationTdap, tetanus-diphtheria-acellular pertussis vaccineUIC, Urban Influence CodesVaccinationsWIR, Wisconsin Immunization Registry

Identifiers

PMID35755142
PMCPMC9218554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.